Emergence of multidrug-resistant Salmonella enterica serotype Newport in Minnesota

Vanessa C Lopes1, Stephanie D Wedel, Jeffrey B Bender

  • 1Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul 55108, USA.

Insights

Multidrug-resistant Salmonella Newport infections are increasing in Minnesota. Analysis suggests a single clone may be responsible for the rise in resistant Salmonella enterica serotype Newport cases in both animals and humans.

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Salmonella enterica serotype Newport (S. Newport) is a significant cause of foodborne illness.
  • Increasing antimicrobial resistance in bacterial pathogens poses a global health threat.

Purpose of the Study:

  • To investigate the concurrent increase in S. Newport isolates and multidrug resistance (MDR) in Minnesota.
  • To determine the genetic relatedness and resistance profiles of MDR S. Newport isolates.

Main Methods:

  • Antimicrobial susceptibility testing was performed on S. Newport isolates from human and animal sources.
  • Pulsed-field gel electrophoresis (PFGE) was used to analyze the genetic diversity of the isolates.
  • Class 1 integrons were identified in resistant isolates.

Main Results:

  • A concurrent rise in the number of S. Newport isolates and MDR rates was observed in Minnesota.
  • PFGE analysis revealed heterogeneity among isolates but identified a major cluster.
  • This cluster predominantly contained MDR isolates with a specific resistance pattern and class 1 integrons.

Conclusions:

  • The findings suggest a clonal expansion of a specific MDR S. Newport strain.
  • This clonal strain appears to be circulating in both animal and human populations in Minnesota.
  • Public health surveillance and control measures are crucial to address the spread of MDR S. Newport.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...